SBSI’s products are mainly laboratory instruments (semi-automated to fully-automated) and their corresponding consumables. They are intended to automate and revolutionize the manual laboratory procedures into amazing technological innovations.
The in-vitro diagnostics market segments in which it is actively present in are: Hematology, Clinical Chemistry, Immunochemistry, Immunohematology, Coagulation, Serology, Microbiology, Molecular Biology, and some other specialized segments.
SBSI is currently the market leader for electrophoresis testing in the Philippines and one of the top three players in Clinical Hematology and Coagulation.
With its introduction of the National Institutes of Health-approved G-6PD confirmation test through its Pentra 400 chemistry instrument, it is now posing itself as a strong challenger in the medium-sized market in Clinical Chemistry.